Pacific Biosciences of California, Inc.
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.795 USD | +4.36% | -2.46% | -81.80% |
05-09 | Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q1 Revenue $38.8M | MT |
04-22 | JPMorgan Downgrades Pacific Biosciences of California to Neutral From Overweight | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.80% | 468M | |
+11.31% | 221B | |
+9.09% | 186B | |
+14.61% | 137B | |
+27.52% | 109B | |
-0.04% | 63.09B | |
+13.72% | 52.68B | |
+4.86% | 50.86B | |
+7.49% | 42.53B | |
+7.45% | 37.76B |
- Stock Market
- Equities
- PACB Stock
- News Pacific Biosciences of California, Inc.
- Piper Sandler Trims Price Target on Pacific Biosciences of California to $8 From $9, Maintains Neutral Rating